Infectologia

Revisão | Uso de antibióticos para infecções de corrente sanguínea na UTI.

28 Abr, 2022 | 11:44h

Use of Antimicrobials for Bloodstream Infections in the Intensive Care Unit, a Clinically Oriented Review – Antibiotics

Sintomas persistentes de COVID-19 em estudo comunitário de 606.434 pessoas na Inglaterra.

27 Abr, 2022 | 16:41h

Persistent COVID-19 symptoms in a community study of 606,434 people in England – Nature Communications

Comentário no Twitter

Thirty-eight percent of participants from a community-based study of symptoms following COVID-19 reported persistent symptoms that lasted 12 weeks or more, according to an article published in @NatureComms. https://t.co/sAEutdOkSS pic.twitter.com/oCyyXGIRbk

— Nature Portfolio (@NaturePortfolio) April 20, 2022

Covid-19: estudo mostra que somente 1/4 dos pacientes admitidos em hospital sentem-se completamente recuperados após 1 ano.

27 Abr, 2022 | 16:39h

Covid-19: Only a quarter of patients admitted to hospital feel fully recovered after a year, study finds – The BMJ

Estudo original: Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study – The Lancet Respiratory Medicine

Comentário convidado: Long COVID: systemic inflammation and obesity as therapeutic targets – The Lancet Respiratory Medicine

Comentário no Twitter (fio – clique para saber mais)

PHOSP-COVID study:
– 232 (29%) of 804 pts fully recovered at 1y
– Female sex, obesity, & IMV = less likely to feel fully recovered
– inflamm mediators📈in those w/ most severe physical, mental health, & cognitive impairments

Read it here: https://t.co/rVZuVDo4xl

— The Lancet Respiratory Medicine (@LancetRespirMed) April 25, 2022

Estudo de coorte | Gravidade da COVID-19 e trajetória da morbidade da saúde mental em populações de pacientes de 6 nações.

27 Abr, 2022 | 16:35h

Acute COVID-19 severity and mental health morbidity trajectories in patient populations of six nations: an observational study – The Lancet Public Health

Comunicado de imprensa: Study suggests association between severe COVID-19 and long-term mental health outcomes 16 months after an illness – Lancet

Comentário: Lasting depression and anxiety can follow severe case of Covid – NBC News

Comentário no Twitter (fio – clique para saber mais)

In our study published in the @TheLancetPH, we found that a mild course of acute illness (never bedridden due to #COVID19) was associated with a persistently lower risk of adverse #mentalhealth outcomes. https://t.co/aHBQTaOi4K

Several factors might contribute to this pattern🔽

— COVIDMENT research project (@COVIDMENT) April 11, 2022

Sim, recaídas após Paxlovid acontecem – e agora?

27 Abr, 2022 | 16:33h

Yes, Relapses After Paxlovid Happen — Now What? – HIV and ID Observations

Comentário no Twitter

Some additional thoughts about relapsing Covid19 after treatment with Paxlovid.

Bottom line — *lots* of unknowns, starting w/ how often it happens.

Looking forward to @pfizer sharing further data on the relapsing cases from their EPIC-HR study. https://t.co/1MMhqn4elw

— Paul Sax (@PaulSaxMD) April 25, 2022

Estudo de coorte | Efetividade de doses de reforço homólogas vs. heterólogas para vacina com SARS-CoV-2 inativado.

27 Abr, 2022 | 16:26h

Effectiveness of homologous and heterologous booster doses for an inactivated SARS-CoV-2 vaccine: a large-scale prospective cohort study – The Lancet Global Health

Comentários:

COVID-19 vaccine booster strategy: striving for best practice – The Lancet Global Health

Covid-19: Mix and match booster vaccination approach offers best protection, study reports – The BMJ

Comentário no Twitter

Effectiveness of homologous and heterologous booster doses for an inactivated SARS-CoV-2 vaccine: a large-scale prospective cohort study https://t.co/0k7WlphoDV Heterologous booster provided ⬆️ protection than homologous one, especially when Coronavac vaccine had been used.

— Carlos del Rio (@CarlosdelRio7) April 25, 2022